Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Tokyo-listed (NTDOY) gaming hardware and IP company with 140M+ Switch units sold; Nintendo Switch 2 launching 2025 competing with PlayStation 5 through exclusive Mario, Zelda, and Pokémon franchises.
Nintendo is a Kyoto-based global gaming company that develops gaming hardware, software, and entertainment experiences — producing iconic first-party game franchises including Super Mario, The Legend of Zelda, Pokémon, Metroid, Animal Crossing, Splatoon, and Kirby, alongside the Nintendo Switch hybrid gaming console (home console + handheld in one device). Listed on the Tokyo Stock Exchange (TYO: 7974 / OTC: NTDOY), Nintendo generated approximately ¥1.67 trillion ($11 billion) in net sales in fiscal year 2024, with the Nintendo Switch installed base exceeding 140 million units globally — the third best-selling gaming platform in history.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.